Private and statutory health insurance the prejudice of pampered private patients and of the insured person in second class in the statutory health insurance is widely used. But how much truth in these archetypes? The private krankenversicherung.de insurance Portal reports on the situation in the field of drug supply. Data from new private health insurers in 2008 are based on the examination of the Scientific Institute of the private health insurance. The comparison (comparison /) by legally insured and privately insured patients shows former significantly more common generic drugs that are prescribed. While private patients only in 51.4 percent of all cases are given such a generic product, the number of legally insured nearly 90 percent is reached. However, increased this ratio even in private insured as compared to the previous year by five percent. Privately insured persons are also better off than by law with regard to innovative products and non-prescription drugs Insured.
Due to high co-payments or complete deletion of the catalogue of services legally insured patients very rarely appropriate medicines. Even products like Elmex jelly, which is offered in every corner drugstore, be covered by private health insurance. Such products make up about two-thirds of all the regulations of non-prescription products, take the private patients annually. A similar picture of the Betterment of private patients are emerging in the field of innovation products. While, for example, the Cholesterinsenkungsmittel Sortis in the statutory health insurance due to the high surcharge scarcely of importance, it is the most prescribed drug in patients with private health insurance. More information: news.private-krankenversicherung.de/…/ private patient with drugs… Lisa Neumann University first media GmbH